Option Care Health, Inc. (NASDAQ:OPCH) Stock Position Decreased by Bridgewater Associates LP

Bridgewater Associates LP cut its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 87.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,706 shares of the company’s stock after selling 190,886 shares during the period. Bridgewater Associates LP’s holdings in Option Care Health were worth $836,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in OPCH. UMB Bank n.a. raised its stake in shares of Option Care Health by 937.5% during the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company’s stock worth $26,000 after purchasing an additional 750 shares in the last quarter. GAMMA Investing LLC raised its stake in shares of Option Care Health by 110.6% during the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after purchasing an additional 471 shares in the last quarter. Whittier Trust Co. of Nevada Inc. raised its stake in shares of Option Care Health by 3,362.8% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after purchasing an additional 1,446 shares in the last quarter. Blue Trust Inc. raised its stake in shares of Option Care Health by 14.8% during the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock worth $81,000 after purchasing an additional 377 shares in the last quarter. Finally, International Assets Investment Management LLC raised its stake in shares of Option Care Health by 3,029.7% during the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock worth $91,000 after purchasing an additional 2,757 shares in the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the firm’s stock in a transaction dated Friday, November 8th. The shares were bought at an average price of $22.54 per share, with a total value of $969,220.00. Following the acquisition, the director now owns 326,334 shares of the company’s stock, valued at $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on OPCH shares. Bank of America downgraded Option Care Health from a “buy” rating to a “neutral” rating and cut their price objective for the company from $43.00 to $29.00 in a research note on Wednesday, October 30th. JMP Securities raised their price objective on Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research note on Monday, September 30th. Barrington Research cut their price objective on Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research note on Thursday, October 31st. The Goldman Sachs Group downgraded Option Care Health from a “buy” rating to a “neutral” rating and cut their price objective for the company from $38.00 to $27.00 in a research note on Monday, November 4th. Finally, Jefferies Financial Group downgraded Option Care Health from a “buy” rating to a “hold” rating and cut their price objective for the company from $38.00 to $26.00 in a research note on Thursday, October 31st. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $30.83.

Option Care Health Stock Performance

OPCH opened at $23.80 on Monday. The firm has a market capitalization of $4.05 billion, a P/E ratio of 20.00, a price-to-earnings-growth ratio of 2.46 and a beta of 1.32. The stock’s 50 day moving average price is $26.84 and its two-hundred day moving average price is $28.87. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $34.63.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.